Xing Li

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Signaling Pathway

Systematic Review

Inflammatory Response

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Journal of clinical pharmacy and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Shengqi Niu, Manyi Jing, Jian-Xia Wen, Shizhang Wei, Haotian Li, Xing Li, Xiao Ma, Yan-Ling Zhao
Jatrorrhizine Alleviates DSS-Induced Ulcerative Colitis by Regulating the Intestinal Barrier Function and Inhibiting TLR4/MyD88/NF- κ B Signaling Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Xing Li, Shizhang Wei, Xiao Ma, Haotian Li, Manyi Jing, Honghong Liu, Yanling Zhao
Efficacy and safety of Tanreqing injection combined with antibiotics against Streptococcus pneumoniae pneumonia: A systematic review and meta-analysis. Journal of clinical pharmacy and therapeutics 47 (8) (2022)
Xing Li, Shizhang Wei, Xiao Ma, Haotian Li, Manyi Jing, Honghong Liu, Shengqi Niu, Yuling Tong, Lisheng Chen, Ying Wei, Sichen Ren, Yan-Ling Zhao
Huanglian Jiedu Decoction Exerts Antipyretic Effect by Inhibiting MAPK Signaling Pathway. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)